EMA Opens Registration for European Network of Paediatric Research Workshop
EMA opens registration for it's sixth annual workshop on pediatric drug research and development.
The European Medicines Agency (EMA) has begun registration for its sixth workshop of the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA). The workshop will take place at EMA’s headquarters in London on June 26-27, 2014. The workshop, which aims to strengthen communication between stakeholders, will update participants from all aspects of the industry on “Enpr-EMA’s efforts to foster high-quality paediatric drug research and to contribute to the ongoing development of research and clinical trials in the area of paediatric medicine.”
Enpr-EMA, which is comprised by a network of research networks, investigators, and centers with expertise in performing clinical studies in children, fosters ethical research on the quality, safety and efficacy of medicines for use in children; helps recruit patients for clinical trials, and creates collaboration between networks.
Workshop registration forms can be found on EMA’s website) and should be submitted to enprema@ema.europa.eu.
Novo Nordisk Hemophilia Treatment Gets Positive Opinion from CHMP
October 23rd 2024As many as 30% of people living with severe hemophilia A develop inhibitors such as TFPI, which can be produced by the body’s immune response to clotting factors in replacement therapy, often limiting the effectiveness of that therapy.
